## Pathological Features of Cholesteatoma ### Correct Answer: Presence of a fibrous capsule separating the lesion from surrounding bone (Option D) **Key Point:** Cholesteatoma does **NOT** possess a true fibrous capsule separating it from surrounding bone. Unlike benign cysts or encapsulated tumors, cholesteatoma is characterized by **invasive, non-encapsulated** growth of keratinizing squamous epithelium that directly erodes adjacent bony structures — making Option D the feature that is NOT recognized in cholesteatoma pathology. ### Why Option D Is the Correct "NOT" Answer Cholesteatoma is fundamentally an **invasive lesion**. Its hallmark is the direct interface between the squamous epithelial matrix (the "skin sac") and bone, without any intervening fibrous capsule. The absence of encapsulation is precisely what enables: - Direct osteoclast activation at the epithelial-bone interface - Progressive erosion of the ossicular chain, tegmen tympani, lateral semicircular canal, and facial nerve canal - High recurrence rates after incomplete surgical removal (necessitating second-look procedures) A fibrous capsule would imply a contained, non-invasive lesion — the exact opposite of cholesteatoma's pathological behavior as described in Schuknecht's *Pathology of the Ear* and Scott-Brown's *Otorhinolaryngology*. ### Recognized Pathological Features of Cholesteatoma (Options A, B, C) | Feature | Mechanism | Clinical Significance | |---------|-----------|----------------------| | **Keratin debris + granulation tissue at margin (Option A)** | Desquamation of squamous epithelium; chronic inflammation at periphery | Creates mass effect, infection nidus, and inflammatory mediator release | | **Bone resorption via RANKL signalling (Option B)** | Epithelial cells express RANKL → osteoclast activation; also IL-1, IL-6, TNF-α, PGE₂ | Explains erosion of ossicles, canal wall, tegmen, and semicircular canal | | **Squamous epithelium with intact basement membrane (Option C)** | Keratinizing stratified squamous epithelium lines the lesion; basement membrane is retained | Distinguishes cholesteatoma matrix from invasive squamous cell carcinoma, where basement membrane is breached | > **Note on Option C:** The squamous epithelium lining cholesteatoma retains a basement membrane — this is a recognized feature that distinguishes it from malignant transformation. *Loss* of basement membrane integrity is a feature of carcinoma, not cholesteatoma. Hence Option C describes a genuine pathological feature of cholesteatoma and is NOT the answer. **High-Yield:** The invasive, non-encapsulated nature of cholesteatoma — with direct epithelial-bone contact mediated by RANKL/osteoclast signaling and inflammatory cytokines — is the central concept tested in NEET PG/INI-CET. The **absence** of a fibrous capsule is what makes cholesteatoma destructive and prone to recurrence. **Clinical Pearl:** At surgery (canal wall down or intact canal wall mastoidectomy), the absence of a capsule means even microscopic residual matrix can regenerate a full cholesteatoma — hence the need for second-look procedures at 12–18 months. [cite: Schuknecht HF — *Pathology of the Ear*, 2nd ed.; Glasscock-Shambaugh — *Surgery of the Ear*, 6th ed.; Scott-Brown's *Otorhinolaryngology, Head and Neck Surgery*, 8th ed.; Dhingra PL — *Diseases of Ear, Nose and Throat*, 7th ed.]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.